Amarin Shares Rally Big; Will Fish Oil Pill Let People Eat What They Want?
Will Johnson & Johnson Cure Cancer?
Can Dendreon Become the "Next Dendreon"?
Vivus Investors Rejoice as Weight Loss Drug Receives Positive Panel Vote
Madison Square Investors Buy into Linsanity
Is Abercrombie & Fitch About to Lose its Luster?
Will GM Ever Catch Up to Ford?
Pep Boys Goes Private, Accepts $791 Million Private Equity Offer
Will Solutia be the Solution for Eastman Chemical?
Will Roche's Takeover Bid Help People Predict Diseases?
Is Coach Still America's Premier Luxury Brand?
Is JC Penney Following its Cost Cutting Rivals?
Target Misses Again, Delays Credit Card Portfolio Sale
Will This Airline Make Your Travel Even More Stressful?
Is Tiffany Still a Match Made in Heaven for Investors?
Forget Dendreon, Inhibitex is the New Biotech Success Story
Can This Pharmaceutical Company Make You Rich?
Can J.C. Penney Capture Some of Apple's Retail Magic?
Are Americans Ready to Buy Cars Again?
Will GE Make You Money in 2012?